abstract |
The present invention relates to methods for preventing or treating diseases or conditions associated with platelet aggregation. This method also relates to a method of treating thrombosis or related disorders. The method comprises administering to a subject a pharmaceutical composition containing an effective amount of a non-nucleotide compound, preferably a P2Y 12 receptor antagonist compound, wherein the amount is effective to inhibit platelet aggregation. It is. Compounds useful in the present invention include compounds of general formulas I and III-XI, or salts, hydrates and solvates thereof. The present invention also provides novel compounds of formulas I and III-XI. |